Clinical Trials Sponsored by Parkinson's UK

Total 1174 results

University Hospital, Basel, Switzerland
Velux Fonden; Lumie UK

Completed

Circadian Sleep-wake Cycles and Light Therapy in Borderline Personality Disorder

Depression | Borderline Personality Disorder | Sleep Disturbances

Switzerland
Loughborough University
Bridge Farm Nurseries Limited, Spalding, UK

Recruiting

Physiological and Appetitive Effects of CBD Supplementation

Appetitive Behavior | Adverse Effect | Metabolic Health

United Kingdom
Reckitt Benckiser Healthcare (UK) Limited
University of Leeds

Completed

Retention, Stability and Performance Assessment of Denture Fixatives Versus no Fixative Control (RESONATE)

Dentures

United Kingdom
Nutricia UK Ltd
National Health Service, United Kingdom

Completed

High Energy High Protein Peptide Feed Study

Malnutrition | Malabsorption

United Kingdom
University of Oxford
Cancer Research UK; Akamis Bio

Completed

Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer (CEDAR)

Locally Advanced Rectal Cancer

United Kingdom
University of Oxford
Boehringer Ingelheim; Prostate Cancer UK

Active, not recruiting

Windows Trial of INsulin-like Growth Factor Neutralising Antibody Xentuzumab in MEN Scheduled for Radical Prostatectomy (WINGMEN) (WINGMEN)

Prostate Cancer

United Kingdom
Barts & The London NHS Trust
Innovate UK; Andiamo

Completed

3D Printed Orthotics in Children Adolescents (PRINT)

Cerebral Palsy | Ankle Foot Orthosis (AFO)

United Kingdom
MeiraGTx UK II Ltd
Janssen Research & Development, LLC

Completed

Gene Therapy for Achromatopsia (CNGA3) (CNGA3)

Achromatopsia

United Kingdom, United States
Imperial College London
Cancer Research UK; Waters Corporation

Completed

Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study (REI-EXCISE)

Breast Cancer | Surgery

United Kingdom
Royal Free Hospital NHS Foundation Trust
Innovate UK

Active, not recruiting

CirrhoCare in COVID-19: A Pilot, Remote, Home Monitoring Study in Advanced Cirrhosis

Decompensated Cirrhosis

United Kingdom
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK (ECOS UK)

Growth Disorders

United Kingdom
Federation Francophone de Cancerologie Digestive
Biocompatibles UK Ltd

Completed

Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Unresectable Liver Metastases: a Phase II Multicenter Study

Colorectal Cancer With Non Resectable Hepatic Metastasis

France
University of Leeds
Karyopharm Therapeutics Inc; Myeloma UK

Withdrawn

Pembrolizumab Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma (MUKfourteen)

Myeloma Multiple

United Kingdom
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients

Relapsing Multiple Sclerosis

United Kingdom
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device (READER)

Relapsing Multiple Sclerosis

United Kingdom
Kyowa Hakko Kirin UK, Ltd.

Completed

A Study of KW-3357 in Congenital Antithrombin Deficiency

Congenital Antithrombin Deficiency

France, Germany, Italy, Sweden, United Kingdom
Pfizer
Diabetes UK; Department of Health, United Kingdom

Completed

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events (CARDS)

Angina, Unstable | Cerebrovascular Accident | Coronary Artery Bypass Graft | Revascularization | Major Coronary Event

United Kingdom
University of Alabama at Birmingham
Michael J. Fox Foundation for Parkinson's Research

Not yet recruiting

Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)

Parkinson Disease

United States
University of Alabama at Birmingham
Michael J. Fox Foundation for Parkinson's Research

Completed

Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology

Parkinson Disease | Dystonia-Parkinsonism, Adult-Onset

United States
Wake Forest University Health Sciences
Michael J. Fox Foundation for Parkinson's Research

Withdrawn

Using Neuromodulation to Improve Parkinson's Disease

Parkinson Disease

United States
Oregon Health and Science University
Michael J. Fox Foundation for Parkinson's Research

Completed

Effects of Cholinergic Augmentation on Measures of Balance and Gait

Parkinson's Disease

United States
University of California, Los Angeles
Michael J. Fox Foundation for Parkinson's Research

Terminated

Treating H. Pylori in Parkinson's Patients With Motor Fluctuations

Parkinson's Disease | Helicobacter Infections | Motor Fluctuations

United States
Lancashire Teaching Hospitals NHS Foundation Trust
Duchenne UK

Recruiting

Hydrotherapy in Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United Kingdom
Defence Medical Rehabilitation Centre, UK
University of Bath

Recruiting

Acute Physiological Responses to Twice Daily Blood Flow Restriction Training

Muscle Weakness | Muscle Damage

United Kingdom
Defence Medical Rehabilitation Centre, UK
University of Bath

Recruiting

The ADAPTation to Therapeutic Resistance Training (ADAPT) Study

Muscle Weakness | Musculoskeletal Injury

United Kingdom
The Christie NHS Foundation Trust
Prostate Cancer UK

Recruiting

Hypoxia-driven Prostate Cancer Genomics (HYPROGEN) (HYPROGEN)

Hypoxia | Prostate Cancer

United Kingdom
University of Leeds
Celgene; Janssen, LP; Myeloma UK

Active, not recruiting

MUK Nine b: OPTIMUM Treatment Protocol (MUKnineb)

Multiple Myeloma

United Kingdom
Glasgow Caledonian University
NHS Lanarkshire; MS Society, UK

Completed

Immersive Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Paion UK Ltd.
Chiltern International Ltd.; HFL Ltd.

Completed

An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours

Postoperative Pain

France, Germany, Netherlands, Poland, United Kingdom, Czechia
The Christie NHS Foundation Trust
Pancreatic Cancer UK

Completed

Pancreatic Cancer Dietary Assessment Study (PanDA)

Pancreas Adenocarcinoma | Pancreatic Neoplasm | Malignant Neoplasm of Pancreas | Well-Differentiated Neuroendocrine Carcinoma

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
Diabetes UK

Completed

Study of CBME in the Relief of Painful Diabetic Neuropathy

Diabetic Neuropathy | Painful

United Kingdom
Izana Bioscience Ltd.
Iqvia Pty Ltd; Innovate UK

Completed

Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis (NAMASTE)

Axial Spondyloarthritis

United Kingdom
Queen Mary University of London
Cancer Research UK

Completed

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ (IBIS-II DCIS)

Breast Cancer

France, Switzerland, Ireland, United Kingdom, Italy, Australia, Austria, Belgium, Chile, Germany, Hungary, Malta, Sweden, Turkey
Medical University of Graz
Neoss Ltd., Harrogate, UK

Completed

Two Interforaminal Implants in an Immediate or Delayed Loading Protocol for the Elderly

Edentulous Jaw

Austria
University of Leeds
Millennium Pharmaceuticals, Inc.; Myeloma UK

Unknown

Phase II Randomised Trial of Cyclophosphamide and Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma. (MUKEight)

Multiple Myeloma

United Kingdom
M.D. Anderson Cancer Center
Daiichi Sankyo UK Ltd.

Terminated

Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma

Myeloma

United States
Royal Marsden NHS Foundation Trust
Cancer Research UK

Unknown

CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study (CHEMO-T)

Angioimmunoblastic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Negative | Peripheral T-cell Lymphoma NOS | Hepatosplenic Gamma/ Delta T-cell Lymphoma

United Kingdom
The University of Hong Kong
Dementias Platform UK

Unknown

The University of Hong Kong Neurocognitive Disorder Cohort

Mild Cognitive Impairment | Vascular Dementia | Alzheimer Dementia | Neurocognitive Disorder | Age-related Cognitive Decline

Hong Kong
ClinSearch
Biocompatibles UK Ltd; European Georges Pompidou Hospital

Unknown

Prostate Embolization for Acute Urinary Retention Study (PARIS1)

Prostatic Hypertrophy, Benign

France
Macmillan Research Group UK
NMP Medical Research Institute

Completed

Impact of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence

Domestic Violence

India
NMP Medical Research Institute
Macmillan Research Group UK

Completed

Enhancing Medical Compliance and Health-related Quality of Life of Patients With Epilepsy

Epilepsy
Oxford University Hospitals NHS Trust
Cancer Research UK

Completed

Effect of Metformin on Breast Cancer Metabolism

Breast Cancer

United Kingdom
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice (RESECT)

Metastatic Colorectal Cancer

United Kingdom
Oxford University Hospitals NHS Trust
The Dystonia Society of the United Kingdom; Globsource UK; Statsconsultancy Ltd...

Completed

A Mechanical Device for Blepharospasm

Blepharospasm
Barts & The London NHS Trust
Cancer Research UK; UK: Barts Center for Experimental Cancer Medicine (CECM)...

Unknown

A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma (ADAM)

Malignant Pleural Mesothelioma

United Kingdom
Northwestern University
University of Pittsburgh; The Parkinson Study Group

Recruiting

Study in Parkinson Disease of Exercise (SPARX3)

Parkinson Disease

United States, Canada
Hospital de Clinicas de Porto Alegre
Michael J. Fox Foundation for Parkinson's Research

Recruiting

Prodromal and Overt Parkinson's Disease Epidemiological Study in Brazil (PROBE-PD)

Parkinson Disease | Parkinsonism

Brazil
Ryan D'Arcy
University of British Columbia; Pacific Parkinson's Research Institute

Completed

Multimodal Neuromodulation in Individuals With Parkinson's Disease

Parkinson Disease

Canada
Parkinson's Disease and Movement Disorder Center...
Bausch Health Americas, Inc.

Completed

Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists (AtoZ)

Parkinson's Disease

United States
University Hospital Muenster
Deutsche Parkinson Vereinigung e.V. (dPV)

Completed

EMST and TMS for Treatment of Dysphagia in Parkinson's Disease

Parkinson's Disease

Germany

Clinical Trials Sponsored by Parkinson's UK

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations